alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › clinical-utility

clinical-utility

8 studies tagged clinical-utility, dated 2018-03-20 to 2026-08-28. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Real-world long-term continuation of lecanemab therapy and the clinical utility of phosphorylated tau 181 2026-08-28
  2. Clinical utility of plasma p-tau217 in identifying abnormal brain amyloid burden in an Asian cohort with high prevalence of concomitant cerebrovascular disease 2025-01-14
  3. Clinical Utility of an Alzheimer's Disease Blood Test Among Cognitively Impaired Patients: Results from the Quality Improvement PrecivityAD2 (QUIP II) Clinician Survey Study 2025-01-13

Studies

8 studies carry this tag.

Date range

2018 to 2026

Top journals

  • Alzheimer's & dementia (Amsterdam, Netherlands) 1
  • Alzheimer's & dementia : the journal of the Alzheimer's Association 1
  • Alzheimer's research & therapy 1
  • Annals of clinical and translational neurology 1
  • Diagnostics (Basel, Switzerland) 1

8 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Real-world long-term continuation of lecanemab therapy and the clinical utility of phosphorylated tau 181

    ✓ Peer-reviewed alzhub usefulness score 59 out of 100. The journal of prevention of Alzheimer's disease 2026-08-28 Treatments

    This real-world study evaluated the long-term feasibility of lecanemab treatment in 117 patients with early Alzheimer's disease at Kanazawa University Hospital.

  2. Clinical utility of plasma p-tau217 in identifying abnormal brain amyloid burden in an Asian cohort with high prevalence of concomitant cerebrovascular disease

    ✓ Peer-reviewed alzhub usefulness score 66 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2025-01-14 Biomarkers

    Risk stratification for PET Aβ+ based on a plasma p-tau217 assay demonstrated potential diagnostic and prognostic utility in an Asian cohort with concomitant CeVD.

  3. Clinical Utility of an Alzheimer's Disease Blood Test Among Cognitively Impaired Patients: Results from the Quality Improvement PrecivityAD2 (QUIP II) Clinician Survey Study

    ✓ Peer-reviewed alzhub usefulness score 57 out of 100. Diagnostics (Basel, Switzerland) 2025-01-13 Biomarkers

    Patients had a median age of 74, 53% were female, and 28% were traditionally under-represented in Black, Hispanic, and Asian groups.

  4. Clinical utility of plasma Aβ42/40 ratio by LC-MS/MS in Alzheimer's disease assessment

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Frontiers in neurology 2024-03-25 Biomarkers

    High-throughput plasma Aβ42/40 LC-MS/MS assays can help identify patients with low likelihood of AD pathology, which can reduce PET evaluations, allowing for cost savings.

  5. Clinical Utility of Tau Positron Emission Tomography in the Diagnostic Workup of Patients With Cognitive Symptoms

    ✓ Peer-reviewed alzhub usefulness score 74 out of 100. JAMA neurology 2023-07-01 Brain scans and imaging

    The study team reported a significant change in diagnoses and patient medication when tau PET was added to an already extensive diagnostic workup that included cerebrospinal fluid AD biomarkers.

  6. Clinical utility of an antibody-free LC-MS method to detect brain amyloid deposition in cognitively unimpaired individuals from the screening visit of the A4 Study

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Alzheimer's & dementia (Amsterdam, Netherlands) 2023-04-01 Biomarkers

    ABtest-MS accurately identified brain amyloid deposition in a population of CU individuals, supporting its implementation in AD secondary prevention trials to reduce recruitment time and costs.

  7. Clinical utility of cerebrospinal fluid biomarkers measured by LUMIPULSE® system

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Annals of clinical and translational neurology 2022-11-02 Biomarkers

    CSF biomarkers measured with the LUMIPULSE system showed good agreement with amyloid PET imaging.

  8. Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. Alzheimer's research & therapy 2018-03-20 Biomarkers

    There were significant global differences in Aβ1-42, T-tau, T-tau/Aβ1-42 ratio, P-tau-181, NFL, AβX-42, AβX-42/X-40 ratio, APPα, and APPβ between groups.

All topic tags with their study counts